Literature DB >> 9096690

Effects of antisense p21 (WAF1/CIP1/MDA6) expression on the induction of differentiation and drug-mediated apoptosis in human myeloid leukemia cells (HL-60).

A J Freemerman1, J A Vrana, R M Tombes, H Jiang, S P Chellappan, P B Fisher, S Grant.   

Abstract

The p21MDA6 gene product induces cell cycle arrest in p53-null human leukemic cells exposed to differentiation stimuli. We employed an HL-60 cell line stably transfected with a p21MDA6 antisense construct to compare the effects of p21MDA6 dysregulation on the response of myeloid leukemia cells to differentiating and cytotoxic agents. Antisense-expressing cells (HL-60/AS5) treated with 5 nM PMA for 24 h exhibited attenuated induction of p21MDA6 compared to empty vector controls (HL-60/V2). This phenomenon was accompanied by a reduction in the percentage of cells undergoing G1 arrest (67.6 +/- 4.7 vs 82.9 +/- 1.3; P < or = 0.01) and expressing the monocytic maturation marker cd11b (35.5 +/- 2.8 vs 50.5 +/- 2.4; P < or = 0.005). Although HL-AS5 and HL-60/V2 cells did not exhibit obvious differences in the phosphorylation status of the retinoblastoma protein (pRB), in E2F complex formation, or in p27klp1 induction following PMA exposure, inhibition of activity of cyclin-dependent kinase-2 was attenuated in the antisense-expressing line. A 24-h exposure to 5 nM PMA also reduced the cloning efficiency of HL-60/V2 cells to a significantly greater extent than HL-60/AS5 cells (ie to 30.1 +/- 7.0 vs 57.2 +/- 5.6 of controls; P < or = 0.01). In contrast to the disparate responses to PMA, HL-60/AS5 and HL-60/V2 cells treated with the antimetabolite 1-beta-D-arabinofurano-sylcytosine (Ara-C; 10 microM for 6 h) displayed equal susceptibility to G1 arrest, apoptosis, and inhibition of clonogenicity, phenomena unaccompanied by p21MDA6 and p27klp1 induction, or pRB dephosphorylation. These observations indicate that dysregulation of p21MDA6 in p53-null human myeloid leukemia cells interferes with PMA-related G1 arrest, CDK-2 inhibition, differentiation, and loss of clonogenic survival in the absence of obvious alterations in pRB phosphorylation status or E2F complex formation. They also provide functional evidence that p21MDA6 induction does not appear to be required for Ara-C-induced apoptosis, G1 arrest, or the resulting reduction in the self-renewal capacity of HL-60 cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9096690     DOI: 10.1038/sj.leu.2400625

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  9 in total

Review 1.  Multiple functions of p21 in cancer radiotherapy.

Authors:  Yanbei Kuang; Jian Kang; Hongbin Li; Bingtao Liu; Xueshan Zhao; Linying Li; Xiaodong Jin; Qiang Li
Journal:  J Cancer Res Clin Oncol       Date:  2021-02-05       Impact factor: 4.553

2.  mda-5: An interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties.

Authors:  Dong-chul Kang; Rahul V Gopalkrishnan; Qingping Wu; Eckhard Jankowsky; Anna Marie Pyle; Paul B Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

3.  IkappaB kinase-dependent chronic activation of NF-kappaB is necessary for p21(WAF1/Cip1) inhibition of differentiation-induced apoptosis of monocytes.

Authors:  K N Pennington; J A Taylor; G D Bren; C V Paya
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

4.  Present and Future Prospect of Small Molecule & Related Targeted Therapy Against Human Cancer.

Authors:  Akshat Pathak; Sanskriti Tanwar; Vivek Kumar; Basu Dev Banarjee
Journal:  Vivechan Int J Res       Date:  2018

5.  Cytosolic retention of phosphorylated extracellular signal-regulated kinase and a Rho-associated kinase-mediated signal impair expression of p21(Cip1/Waf1) in phorbol 12-myristate-13- acetate-induced apoptotic cells.

Authors:  Jin-Mei Lai; Sulin Wu; Duen-Yi Huang; Zee-Fen Chang
Journal:  Mol Cell Biol       Date:  2002-11       Impact factor: 4.272

6.  p21(WAF1) modulates drug-induced apoptosis and cell cycle arrest in B-cell precursor acute lymphoblastic leukemia.

Authors:  Carwyn Davies; Linda A Hogarth; Karen L Mackenzie; Andrew G Hall; Richard B Lock
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

7.  Molecular determinants of AHPN (CD437)-induced growth arrest and apoptosis in human lung cancer cell lines.

Authors:  Y Li; B Lin; A Agadir; R Liu; M I Dawson; J C Reed; J A Fontana; F Bost; P D Hobbs; Y Zheng; G Q Chen; B Shroot; D Mercola; X K Zhang
Journal:  Mol Cell Biol       Date:  1998-08       Impact factor: 4.272

Review 8.  The Multifaceted p21 (Cip1/Waf1/CDKN1A) in Cell Differentiation, Migration and Cancer Therapy.

Authors:  Nina-Naomi Kreis; Frank Louwen; Juping Yuan
Journal:  Cancers (Basel)       Date:  2019-08-21       Impact factor: 6.639

Review 9.  MDA-9/Syntenin/SDCBP: new insights into a unique multifunctional scaffold protein.

Authors:  Anjan K Pradhan; Santanu Maji; Swadesh K Das; Luni Emdad; Devanand Sarkar; Paul B Fisher
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.